REFERENCES
- Adams R J, Kutlar A, McKie V, et al, 1993. Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 45: 279–282
- Adekile A D, Kutlar F, Haider M Z, Kutlar A. 2001. Frequency of the 677C → T mutation of the methylenetetrahydrofolate reductase gene among Kuwati sickle cell patients. Am J Hematol. 66: 263–266. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Akinola N O, Steven S ME, Franklin I M, et al, 1992. Rheological changes in the prodromal and established phases of sickle vasoocclusive crisis. Br J Haematol. 81: 598–602. [PUBMED], [INFOTRIEVE]
- Al-Khatti A, Veith R W, Papayannopoulou T, et al, 1987. Stimulation of hemoglobin synthesis by erythropoietin in baboons. N Engl J Med. 317: 415–420. [PUBMED], [INFOTRIEVE]
- Ballas S K, Dover G J, Charache S. 1989. The effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo. Am J Hematol. 32: 104–111. [PUBMED], [INFOTRIEVE]
- Ballas S K, Gay R N, Chehab F F. 1997. Is Hb A2 elevated in adults with sickle-α-thalassemia (Bs/Bs; −α/−α)?. Hemoglobin. 21: 405–420. [PUBMED], [INFOTRIEVE]
- Ballas S K, Larner J, Smith E D, et al, 1998. Rheologic predictors of the severity of the painful sickle cell crisis. Blood. 72: 1216–1223
- Ballas S K, Marcolina M J, Dover G J, Barton F B. 1999. Erythropoietic activity in patients with sickle cell anemia before and after treatment with Hydroxyurea. Br J Haematol. 105: 491–496. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ballas S K, Smith E D. 1992. Red cell changes during the evolution of the sickle cell painful crisis. Blood. 79: 2154–2163. [PUBMED], [INFOTRIEVE]
- Ballas S K, Talacki C A, Rao V M, Steiner R M. 1989. The prevalence of avascular necrosis in sickle cell anemia: correlation with α-thalassemia. Hemoglobin. 13: 649–655. [PUBMED], [INFOTRIEVE]
- Ballas S K. 2000. Hydration of sickle erythrocytes using a herbal extract (Pfaffia paniculata) in-vitro. Br J Haematol. 111: 359–362. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ballas S K. 1991. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells. Am J Hematol. 36: 122–130. [PUBMED], [INFOTRIEVE]
- Baruchel S, Rees J, Bernstein M L, Goodyer P. 1993. Relief of sickle cell priapism by hydralazine. Am J Pediatr Hematol/Oncol. 15: 115–116
- Baum K, Dun D T, Maude G H, Serjeant G R. 1987. The painful crisis of homozygous sickle cell disease: a study of risk factors. Arch Intern Med. 147: 1231–1234. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Bertles J F, Milner P FA. 1968. Irreversibly sickled erythrocytes: a consequence of the heterogeneous distribution of hemoglobin types in sickle-cell anemia. J Clin Invest. 47: 1731–1740. [PUBMED], [INFOTRIEVE]
- Bessis M, Mohandas N. 1975. A diffractometric method for the measurement of cellular deformability. Blood Cells. 1: 307–313
- Bessis M, Mohandas N. 1977. Laser diffraction patterns of sickle cells in shear fields. Blood Cells. 3: 229–239
- Billett H H, Fabry M E, Nagel R L. 1988. Hemoglobin distribution width: a rapid assessment of dense red cells in the steady state and during painful crisis in sickle cell anemia. J Lab Clin Med. 112: 339, [PUBMED], [INFOTRIEVE]
- Blau C A, Constantoulakis P, Shaw C M, et al, 1993. Fetal hemoglobin induction with butyric acid: efficacy and toxicity. Blood. 81: 529–537. [PUBMED], [INFOTRIEVE]
- Boros L, Weiner W J. 1978. Sickle cell anemia and other hemoglobinopathies. Handbook of Clinical Neurology. vol 38, P J, Vinken, G W, Bruyn, Amsterdam, Elsevier. 33–51
- Bridgers W H. 1939. Cerebral vascular disease accompanying sickle cell anemia. Am J Pathol. 15: 353–561
- Briehl R W, Ewert S. 1973. Effects of pH, 2,3-diphosphoglycerate and salts on gelation of sickle cell deoxyhemoglobin. J Mol Biol. 80: 445–458. [PUBMED], [INFOTRIEVE]
- Briehl R W. 1978. Gelation of sickle cell hemoglobin IV. Phase transitions in hemoglobin S gels: separate measures of aggregation and solution-gel equilibrium. J Mol Biol. 123: 521–538. [PUBMED], [INFOTRIEVE]
- Brugnara C, Bunn H F, Tosteson D C. 1986. Regulation of erythrocytes cation and water content in sickle cell anemia. Science. 232: 388–390. [PUBMED], [INFOTRIEVE]
- Brugnara C. DCT, 1987. Inhibition of K transport by divalent cations in sickle erythrocytes. Blood. 70: 1810–1805. [PUBMED], [INFOTRIEVE]
- Brugnara C, de, Franceschi L, Alper S L. 1993. Inhibition of Ca2+-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest. 92: 520–552. [PUBMED], [INFOTRIEVE]
- Brugnara C, Gee B, Armsby C C, et al, 1996. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest. 97: 1227–1234. [PUBMED], [INFOTRIEVE]
- Brugnara C, Kopin A S, Bunn H F, Tosteson D C. 1985. Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest. 75: 1608–1617. [PUBMED], [INFOTRIEVE]
- Charache S, Dover G J, Moore R D, Eckert S, Ballas S K, Koshy M, Milner P FA, Orringer E P, Phillips G, Jr, Platt O S, Thomas G H. 1992. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood. 79: 2555–2565. [PUBMED], [INFOTRIEVE]
- Charache S, Terrin M L, Moore R D, et al, and. the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, 1995. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 332: 1317–1322. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Chien S, King R G, Kaperonis A A, Usami S. 1982. Viscoelastic properties of sickle cells and hemoglobin. Blood Cells. 8: 53–64. [PUBMED], [INFOTRIEVE]
- Chien S, Usami S, Bertles J F. 1970. Abnormal rheology of oxygenated blood in sickle cell anemia. J Clin Invest. 49: 623–634. [PUBMED], [INFOTRIEVE]
- Clark M R, Guatelli J C, White A T, Shohet S B. 1981. Study on the dehydrating effect of the red cell Na+/K+-pump in Nystatin-treated cells with varying Na+ and water contents. Biochim Biophys Acta. 646: 422–432. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Clark M R, Mohandas N, Embury S H, Lubin B H. 1982. A simple laboratory alternative to irreversibly sickle cell (ISC) counts. Blood. 60: 659, [PUBMED], [INFOTRIEVE]
- Clark M R, Mohandas N, Shohet S B. 1980. Deformability of oxygenated irreversibly sickled cells. J Clin Invest. 65: 189–196. [PUBMED], [INFOTRIEVE]
- Clark M R, Mohandas N, Shohet S B. 1983. Osmotic gradient ektacytometry: comprehensive characteristics of red cell volume and surface maintenance. Blood. 61: 899–910. [PUBMED], [INFOTRIEVE]
- Clark M R, Morrison C E, Shohet S B. 1978. Monovalent cation transport in irreversibly sickled cells. J Clin Invest. 61: 329–337
- Collins A F, Dover G J, Luban N LC. 1994. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy. Blood. 84: 1690–1691. [PUBMED], [INFOTRIEVE]
- Corash L M, Piomelli S, Chen H C, Seaman C, Gross E. 1974. Separation of erythrocytes according to age on a simplified density gradient. J Lab Clin Med. 84: 147–151. [PUBMED], [INFOTRIEVE]
- Danish E H, Harris J W. 1983. Viscosity studies of deoxyhemoglobin S: evidence for formation of microaggregates during the lag phase. J Lab Clin Med. 101: 515–526. [PUBMED], [INFOTRIEVE]
- de, Franceschi L, Bachir D, Galacteros F, et al, 1997. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest. 100: 1847–1852. [PUBMED], [INFOTRIEVE]
- de, Jong K, Emerson R K, Butler J, et al, 2001. Short survival of phosphatidylserine exposing red blood cells in murine sickle cell anemia. Blood. 98: 1577–1584. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Dover G J, Brusilow S, Samid D. 1992. Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N Engl J Med. 327: 569–570. [PUBMED], [INFOTRIEVE]
- Eaton W A, Hofrichter J. 1987. Hemoglobin S gelation and sickle cell disease. Blood. 70: 1245–1266. [PUBMED], [INFOTRIEVE]
- Edelstein S J. 1981. Molecular topology in crystals and fibers of hemoglobin S. J Mol Biol. 50: 557–575
- Embury S H, Backer K, Glader B E. 1985. Monovalent cation changes in sickle erythrocytes: a direct reflection of α-globin gene number. J Lab Clin Med. 106: 75–79. [PUBMED], [INFOTRIEVE]
- Embury S H, Clark M R, Monroy G M, Mohandas N. 1984. Concurrent sickle cell anemia and α thalassemia: effect on pathological properties of sickle red cells. J Clin Invest. 73: 116–123. [PUBMED], [INFOTRIEVE]
- Erslev A J. 1983. Erythrokinetics. Hematology, 3rd ed., W J, Williams, E, Beutler, A J, Ersley, M A, Lichtman, New York, McGraw-Hill. 1638–1643
- Evans E, Mohandas N, Leung A. 1984. Static and dynamic rigidities of normal and sickle erythrocytes: major influence of cell hemoglobin concentration. J Clin Invest. 73: 477–488. [PUBMED], [INFOTRIEVE]
- Farbry M E, Mears J G, Patel P, Schaefer-Rego K, Carmichael L D, Martinez G, Nagel R L. 1984. Dense cells in sickle cell anemia: the effects of gene interaction. Blood. 64: 1042–1046
- Felice A E, McKie K M, Cleek M P, et al, 1987. Effect of α-thalassemia on the developmental changes of hematological values in children with sickle cell disease from Georgia. Am J Hematol. 25: 389–400. [PUBMED], [INFOTRIEVE]
- Ferrone F A, Hofrichter J, Eaton W A. 1985. Kinetics of sickle hemoglobin polymerization, II: a double nucleation mechanism. J Mol Biol. 183: 611–631. [PUBMED], [INFOTRIEVE]
- Fortier N, Snyder L M, Garver F, et al, 1988. The relationship between in vivo generated hemoglobin skeletal protein complex and increased red cell membrane rigidity. Blood. 71: 1427–1431. [PUBMED], [INFOTRIEVE]
- Fox P D, Higgs D R, Serjeant G R. 1993. Influence of α-thalassemia on the retinopathy of homozygous sickle cell disease. Br J Ophthalmol. 77: 89–90. [PUBMED], [INFOTRIEVE]
- Gill S J, Spokane R, Benedict R C, et al, 1980. Ligand-linked phase equilibria of sickle cell hemoglobin. J Mol Biol. 140: 299–312. [PUBMED], [INFOTRIEVE]
- Girgis R E, Qureshi M A, Abrams J, Swerdlow P. 2003. Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement. Am J Hematol. 72: 177–184, PMID: 12605389 [PubMed—indexed for MEDLINE]. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Goldberg M A, Brugnara C, Dover G J, Schapira L, Charache S, Bunn H F. 1990. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med. 323: 366–372. [PUBMED], [INFOTRIEVE]
- Goldberg M A, Husson M A, Bunn H F. 1977. The participation of hemoglobins A and F in the polymerization of sickle hemoglobin. J Biol Chem. 252: 3414–3421. [PUBMED], [INFOTRIEVE]
- Groner W, Mohandas N, Bessis M. 1980. New optical technique for measuring erythrocyte deformability with the ektacytometer. Clin. Chem.. 26: 1435–1442. [PUBMED], [INFOTRIEVE]
- Hasen H B, Raines S L. 1962. Priapism associated with sickle cell disease. J Urol. 88: 71–76. [PUBMED], [INFOTRIEVE]
- Havel T C, Hillman D, Lessin L S. 1978. Deformability characteristics of sickle cells by microelastimetry. Am J Hematol. 4: 9–17
- Hawker H, Neilson R, Hayes R J, Serjeant G R. 1982. Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease. Br J Haematol. 50: 29–39. [PUBMED], [INFOTRIEVE]
- Hayes R J, Condon P I, Serjeant G R. 1981. Haematologic factors associated with proliferative retinopathy in homozygous sickle cell disease. Br J Ophthalmol. 65: 29–35. [PUBMED], [INFOTRIEVE]
- Hebbel R P, Mohandas N. 1994. Sickle cell adherence. Sickle Cell Disease: Basic Principles and Clinical Practice, S H, Embury, R P, Hebbel, N, Mohandas, M H, Steinberg, New York, Raven. 217–230
- Hofrichter J, Ross P D, Eaton W A. 1976. A physical description of hemoglobin S gelation. Proceedings of the Symposium on Molecular and Cellular Aspects of Sickle Cell Disease, J I, Hercules, G L, Cottan, M R, Waterman, A N, Schechter, Bethesda, MD, DHEW Publ No. (NIH) 76–1007. 185.
- International Committee for Standardization in Hematology, 1980. Recommended method for radioisotope red-cell survival studies. Br J Haematol. 45: 659–666
- Itoh T, Chien S, Usami S. 1992. Deformability measurements on individual sickle cells using a new system with pO2 and temperature control. Blood. 79: 2141–2147. [PUBMED], [INFOTRIEVE]
- Jan K, Usami S, Smith J A. 1982. Effects of transfusion on rheological properties of blood in sickle cell anemia. Transfusion. 22: 17–20. [PUBMED], [INFOTRIEVE]
- Joiner C H. 1993. Cation transport and volume regulation in sickle red blood cells. Am J Physiol. 264, (Cell Physiol 33). C251–C270. [PUBMED], [INFOTRIEVE]
- Joneckis C C, Ackley R L, Orringer E P, Wayner E A, Parise L V. 1993. Integrin α4β1 and glycoprotein IV (CD 36) are expressed on circulating reticulocytes in sickle cell anemia. Blood. 82: 3548–3555. [PUBMED], [INFOTRIEVE]
- Kaufman R. 1992. Hydroxyurea: specific therapy for sickle cell anemia?. Blood. 79: 2503–2506. [PUBMED], [INFOTRIEVE]
- Kaul D K, Fabry M E, Nagel R L. 1989. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci USA. 86: 3356–3360. [PUBMED], [INFOTRIEVE]
- Keidan A J, Noguchi C T, Player M, et al, 1989. Erythrocyte heterogeneity in sickle cell disease: effect of deoxygenation on intracellular polymer formation and rheology of subpopulations. Br J Haematol. 72: 254–261. [PUBMED], [INFOTRIEVE]
- Kennedy A P, Williams B, Meydrech E F, Steinberg M H. 1988. Regional and temporal variation in oscillatory blood flow in sickle cell disease. Am J Hematol. 28: 92–94. [PUBMED], [INFOTRIEVE]
- Khademi M, Marquis J R. 1973. Renal angiography in sickle-cell disease. Radiology. 107: 41–46. [PUBMED], [INFOTRIEVE]
- Klug P P, Kaye N, Jensen W N. 1982. Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells. 8: 175–184. [PUBMED], [INFOTRIEVE]
- Koshy M, Entsuah R, Koranda A, et al, 1989. Leg ulcers in patients with sickle cell disease. Blood. 75: 1403–1408
- Kurantsin-Mills J, Klug P P, Lessin L S. 1988. Vasoocclusion in sickle cell disease: pathophysiology of the microvascular circulation. Am J Pediatr Hematol Oncol. 10: 357–372. [PUBMED], [INFOTRIEVE]
- Lande W M, Andrews D L, Clark M R, et al, 1988. The incidence of painful crisis in homozygous sickle cell disease: correlation with red cell deformability. Blood. 72: 2056–2059. [PUBMED], [INFOTRIEVE]
- Lew V L, Freeman C J, Ortiz O E, Bookchin R M. 1991. A mathematical model of the volume, pH1 and ion content regulation in reticulocytes: application to the pathophysiology of sickle cell dehydration. J Clin Invest. 87: 100–112. [PUBMED], [INFOTRIEVE]
- Lew V L, Hockaday A, Sepulveda M I, et al, 1985. Compartmentation of sickle cell calcium in endocytic inside-out vesicles. Nature. 315: 586–588. [PUBMED], [INFOTRIEVE]
- Lipowsky N H, Sheikh N U, Katz D M. 1987. Intravital microscopy of capillary hemodynamics in sickle cell disease. J Clin Invest. 80: 117–127. [PUBMED], [INFOTRIEVE]
- Longnecker G, Culberson D, Beyers B, et al, 1991. Plasma endothelin (ET) levels are elevated in sickle cell disease (SCD). Blood. 79(suppl 1)202a
- Lopez B L, Barnett J, Ballas S K, Christopher T A, Davis-Moon L, Ma X. 1996. Nitric oxide metabolite levels in acute vasoocclusive sickle-cell crisis. Acad Emerg Med. 3: 1098–103. [PUBMED], [INFOTRIEVE]
- Lopez B L, Kreshak A A, Morris C R, Davis-Moon L, Ballas S K, Ma X L. 2003. L-Arginine levels are diminished in adult acute vasoocclusive sickle cell crisis in the emergency department. Br J Haematol. 120: 532–534, PMID: 12580975 [PubMed—indexed for MEDLINE]. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Mackie L H, Hochmuth R M. 1990. The influence of oxygen tension, temperature, and hemoglobin concentration on the rheological properties of sickle erythrocytes. Blood. 76: 1256–1261. [PUBMED], [INFOTRIEVE]
- Magdoff-Fairchild B, Poillon W N, Li T I, Bertles J F. 1976. Thermodynamic studies of polymerization of deoxygenated sickle cell hemoglobin. Proc Natl Acad Sci USA. 73: 990–994. [PUBMED], [INFOTRIEVE]
- Merkel K HH, Ginsberg P L, Parker J C, Post M JD. 1978. Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation. Stroke. 9: 45–52. [PUBMED], [INFOTRIEVE]
- Messmann R, Gannon S, Sarnaik S, Johnson R M. 1990. Mechanical properties of sickle cell membranes. Blood. 75: 1711–1717. [PUBMED], [INFOTRIEVE]
- Milner P F, Kraus A P, Sebes J I, et al, 1993. Osteonecrosis of the humeral head in sickle cell disease. Clin Orthop. 289: 136–143. [PUBMED], [INFOTRIEVE]
- Milner P F, Kraus A P, Sebes J L, et al, 1991. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 325: 1476–1481. [PUBMED], [INFOTRIEVE]
- Mohandas N, Ballas S K. 1994. Erythrocyte density and heterogeneity. Sickle Cell Disease: Basic Principles and Clinical Practice, SH Embury, RP Habbel, N Mohandas, and MH Steinberg Eds, New York, Raven. 195–203
- Mohandas N, Chasis J A, Shohet S B. 1983. The influence of membrane skeleton on red cell deformability, membrane material properties, and shape. Semin Hematol. 20: 225–242. [PUBMED], [INFOTRIEVE]
- Mohandas N, Chasis J A. 1993. Red cell deformability, membrane material properties and shape: regulation by transmembrane, skeletal and cytosolic proteins and lipids. Semin Hematol. 30: 171–192. [PUBMED], [INFOTRIEVE]
- Mohandas N, Clark M R, Jacobs M S, Shohet S B. 1980. Analysis of factors regulating erythrocyte deformability. J. Clin. Invest.. 66: 563–573. [PUBMED], [INFOTRIEVE]
- Mohandas N, Hebbel R P. 1994. Erythrocyte deformability, fragility, and rheology. Sickle Cell Disease: Basic Principles and Clinical Practice, S H, Embury, R P, Hebbel, N, Mohandas, M H, Steinberg, New York, Raven. 205–215
- Morris C R, Morris S M, Hagar W, Van, Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers F A, Vichinsky E P. 2003. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?. Am J Respir Crit Care Med, [epub ahead of print] PMID: 12626350 [PubMed—as supplied by publisher].
- Mueller B U, Brugnara C. 2001. Prevention of red cell dehydration: a possible new treatment for sickle cell disease. Pediatr Pathol Mol Med. 20: 15–25. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Nagel R L, Bookchin R M, Johnson J, Labie D, Wajcman H, Issac-Sodeye W, Konig G R, Schiliro G, Crookston J H, Matsutomo K. 1979. Structural basis of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of Hb S. Proc Natl Acad Sci USA. 76: 670–674. [PUBMED], [INFOTRIEVE]
- Nagel R L, Erlingsson S, Fabry M E, et al, 1991. The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients. Blood. 77: 1371–1375. [PUBMED], [INFOTRIEVE]
- Nash G B, Johnson C S, Meiselman H. 1986. Influence of oxygen tension on the viscoelastic behavior of red blood cells in sickle cell disease. Blood. 67: 110–118. [PUBMED], [INFOTRIEVE]
- Nash G B, Johnson C S, Meiselman H J. 1984. Mechanical properties of oxygenated red blood cells in sickle cell (HbSS) disease. Blood. 63: 73–80. [PUBMED], [INFOTRIEVE]
- Nibu K, Adachi K. 1985. Effect of FS (α2γβS) hybrid hemoglobin on Hb S nucleation and aggregation. Biochim Biophys Acta. 829: 97–102. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Noguchi C T, Dover G J, Rodgers G P, Serjeant G R, Antonarakia S E, Anagnou N P, Higgs D R, Weatherall D J, Schecter A N. 1985. α-Thalassemia changes erythrocyte heterogeneity in sickle cell disease. J Clin Invest. 75: 1632–1637. [PUBMED], [INFOTRIEVE]
- Noguchi C T, Schechter A N. 1981. The intracellular polymerization of sickle hemoglobin at its relevance to sickle cell disease. Blood. 58: 1057–1068. [PUBMED], [INFOTRIEVE]
- Pagnier J, Mears J G, Dunda-Belkodja O, et al, 1984. Evidence for the multicentric origin of the hemoglobin S gene in Africa. Proc Nat Acad Sci USA. 81: 1771–1773. [PUBMED], [INFOTRIEVE]
- Perrine S P, Ginder G D, Faller D V, et al, 1993. A short-term trial of burtyate to stimulate fetal-globin-gene expression in the b-globin disorders. N Engl J Med. 328: 81–86. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Perutz M F. 1976. Structure and mechanism of haemoglobin. Br Med Bull. 32: 195–208. [PUBMED], [INFOTRIEVE]
- Platt O S, Brambilla D J, Rosse W F, et al, 1994. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 330: 1639–1644. [PUBMED], [INFOTRIEVE]
- Platt O S, Thornington B D, Brambilla D J, et al, 1991. Pain in sickle cell disease: rates and risk factors. N Engl J Med. 325: 11–16. [PUBMED], [INFOTRIEVE]
- Poillon W N, Bertles J F. 1979. Deoxygenated sickle hemoglobin: effects of lyotropic salts on its solubility. J Biol Chem. 254: 3462–3467. [PUBMED], [INFOTRIEVE]
- Powars D R. 1991. Sickle cell anemia βs-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol. 28: 202–208. [PUBMED], [INFOTRIEVE]
- Rhoda M D, Apova M, Beuzard Y, Giraud F. 1985. Compartmentation of Ca2+ in sickle cells. Cell Calcium. 6: 397–411. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Rodgers G P, Dover G J, Noguchi C T, Schechter A N, Nienhuis A W. 1990. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med. 322: 366–372
- Rodgers G P, Dover G J, Uyesaka N, et al, 1993. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med. 328: 73–80. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Rodgers G P, Schechter A N, Nogouchi C T, et al, 1984. Periodic microcirculatory flow in patients with sickle cell disease. N Engl J Med. 311: 1534–1538. [PUBMED], [INFOTRIEVE]
- Ross P D, Hofrichter J, Eaton W A. 1975. Calorimetric and optical characterization of sickle cell hemoglobin gelation. J Mol Biol. 96: 239–256. [PUBMED], [INFOTRIEVE]
- Ross P D, Hofrichter J, Eaton W A. 1977. Thermodynamics of gelation of sickle deoxyhemoglobin. J Mol Biol. 115: 111–134. [PUBMED], [INFOTRIEVE]
- Rothman S M, Fulling K H, Nelson J S. 1986. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol. 20: 684–690. [PUBMED], [INFOTRIEVE]
- Rubin E, Schlegal R A, Williamson P. 1986. Endocytosis in sickle erythrocytes: a mechanism for elevated intracellular Ca2+ levels. J Cell Physiol. 126: 53–59. [PUBMED], [INFOTRIEVE]
- Rybicki A C, Musto S, Swinson G I, et al, 1991. Increased levels of endothelin-1 in plasma of sickle cell anemia patients. Blood. 78(Suppl 1)202a
- Saleh A W, van, Goethem A, Jansen R, et al, 1995. Isobutyramide therapy in patients with sickle cell anemia. Am J Hematol. 49: 244–246. [PUBMED], [INFOTRIEVE]
- Samuel R E, Salmon E D, Briehl R W. 1990. Nucleation and growth of fibers and gel formation in sickle cell haemoglobin. Nature. 345: 833–835. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Sarnaik S, Ballas S K. 2001. Molecular characteristics of pediatric patients with sickle cell anemia and stroke. Am J Hematol. 67: 179–182. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Schmalzer E, Chien S, Brown A K. 1982. Transfusion therapy in sickle cell disease. Am J Pediatr Hematol Oncol. 4: 395–406
- Schmalzer E A, Lee J O, Brown A K, et al, 1987. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels: Implications for transfusion. Transfusion. 27: 228–233. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Schmalzer E Z, Manning R S, Chien S. 1989. Filtration of sickle cells: recruitment into a rigid fraction as a function of density and oxygen tension. J Lab Clin Med. 113: 727–734. [PUBMED], [INFOTRIEVE]
- Serjeant B E, Mason K P, Kenny K W, Stuart J, Higgs D R, Weatheral D J, Hayes R J, Serjeant G R. 1983. Effect of alpha thalassemia on the rheology of homozygous sickle cell disease. Br J Haematol. 55: 479–486. [PUBMED], [INFOTRIEVE]
- Serjeant G R, Serjeant B E. 2001; Sickle Cell Disease, 3rd ed., New York, Oxford University Press
- Setty B N, Kulkarni S, Dampier C D, et al, 2001. Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion. Blood. 97: 2568–2573. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Setty B N, Kulkarni S, Rao A K, et al, 2000. Fetal hemoglobin in sickle cell disease: Relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood. 96: 1119–1124. [PUBMED], [INFOTRIEVE]
- Smith C M, Kuettner J F, Tukey D P, et al, 1981. Variable deformability of irreversibly sickled erythrocytes. Blood. 58: 71–76. [PUBMED], [INFOTRIEVE]
- Sorette M P, Lavenant M G, Clark M R. 1987. Ektacytometric measurement of sickle cell deformability as a continuous function of oxygen tension. Blood. 69: 316–322. [PUBMED], [INFOTRIEVE]
- Steinberg M H, Embury S H. 1986. Thalassemia in blacks: Genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood. 68: 985–990. [PUBMED], [INFOTRIEVE]
- Steinberg M H, Hsu H, Nagel R L, et al, 1995. Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol. 48: 175–181. [PUBMED], [INFOTRIEVE]
- Stockman J A, Nigro M A, Mishkin M M, Oski F A. 1972. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med. 287: 846–850. [PUBMED], [INFOTRIEVE]
- Styles L A, Hoppe C, Klitz W, Vichinsky E, Lubin B, Trachtenberg E. 2000. Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood. 95: 3562–3567. [PUBMED], [INFOTRIEVE]
- Sunshine H R, Hofrichter J, Ferrone F A. 1981. Oxygen binding by sickle cell hemoglobin polymers. J Mol Biol. 158: 251–273
- Swerlick R A, Eckman J R, Kumar A, Jeitler M, Wick T M. 1993. α4β1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood. 82: 1891–1899. [PUBMED], [INFOTRIEVE]
- Talbot J F, Bird A C, Maude G H, et al, 1988. Sickle cell retinopathy in Jamaican children: further observations from a cohort study. Br J Ophthamol. 72: 727–732
- Usami S, Chien S, Bertles J F. 1975. Deformability of sickle cells as studied by microsieving. J Lab Clin Med. 86: 274–279. [PUBMED], [INFOTRIEVE]
- Zwaal R FA, Schroit A J. 1997. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells: a review. Blood. 89: 1121–1132. [PUBMED], [INFOTRIEVE]